150 related articles for article (PubMed ID: 16527861)
1. Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in vitro.
Hogan K; Markos F
Exp Physiol; 2006 May; 91(3):641-6. PubMed ID: 16527861
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the presence of a vagal tachycardia and the effect of vasoactive intestinal polypeptide on rat heart rate in vitro.
Hogan K; Markos F
Pharmacology; 2006; 76(2):101-4. PubMed ID: 16374072
[TBL] [Abstract][Full Text] [Related]
3. The role of neuronal nitric oxide in the vagal control of cardiac interval of the rat heart in vitro.
Sweeney C; Markos F
Auton Neurosci; 2004 Apr; 111(2):110-5. PubMed ID: 15182740
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic type 1 receptors mediate part of nitric oxide's vagal facilitatory effect in the isolated innervated rat right atrium.
Hogan K; Markos F
Nitric Oxide; 2007 Feb; 16(1):110-7. PubMed ID: 16843016
[TBL] [Abstract][Full Text] [Related]
5. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.
Henning RJ; Feliciano L; Coers CM
Cardiovasc Res; 1996 Nov; 32(5):846-53. PubMed ID: 8944815
[TBL] [Abstract][Full Text] [Related]
6. N-desmethylclozapine an M1 receptor agonist enhances nitric oxide's cardiac vagal facilitation in the isolated innervated rat right atrium.
Hogan K; Ahmed O; Markos F
Auton Neurosci; 2007 Dec; 137(1-2):51-5. PubMed ID: 17702668
[TBL] [Abstract][Full Text] [Related]
7. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
Takai N; Yoshida Y; Shida T; Kondo E; Ueda Y; Kiyama H; Tohyama M
Arch Oral Biol; 1997 Mar; 42(3):197-204. PubMed ID: 9188989
[TBL] [Abstract][Full Text] [Related]
8. Vagal postganglionic origin of vasoactive intestinal polypeptide (VIP) mediating the vagal tachycardia.
Markos F; Snow HM
Eur J Appl Physiol; 2006 Nov; 98(4):419-22. PubMed ID: 16896725
[TBL] [Abstract][Full Text] [Related]
9. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
Cunha-Reis D; Ribeiro JA; Sebastião AM
Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
[TBL] [Abstract][Full Text] [Related]
10. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart.
Shvilkin A; Danilo P; Chevalier P; Chang F; Cohen IS; Rosen MR
Cardiovasc Res; 1994 Dec; 28(12):1769-73. PubMed ID: 7867028
[TBL] [Abstract][Full Text] [Related]
11. The potentiation of sinus arrhythmia by vasoactive intestinal polypeptide (VIP) in the anaesthetized dog.
Markos F; Snow HM
Neuropeptides; 2001; 35(5-6):238-43. PubMed ID: 12030808
[TBL] [Abstract][Full Text] [Related]
12. Effect of stimulating non-myelinated vagal axons on atrio-ventricular conduction and left ventricular function in anaesthetized rabbits.
Garcia Perez M; Jordan D
Auton Neurosci; 2001 Jan; 86(3):183-91. PubMed ID: 11270096
[TBL] [Abstract][Full Text] [Related]
13. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
[TBL] [Abstract][Full Text] [Related]
14. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
[TBL] [Abstract][Full Text] [Related]
15. Effects of repetitive vagal stimulation on heart rate and on cardiac vasoactive intestinal polypeptide efflux.
Hill MR; Wallick DW; Martin PJ; Levy MN
Am J Physiol; 1995 May; 268(5 Pt 2):H1939-46. PubMed ID: 7771543
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation.
Brack KE; Coote JH; Ng GA
Cardiovasc Res; 2011 Aug; 91(3):437-46. PubMed ID: 21576131
[TBL] [Abstract][Full Text] [Related]
17. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
18. Opposing effects of vasoactive intestinal polypeptide on gastric motor function in the dorsal vagal complex and the nucleus raphe obscurus of the rat.
Krowicki ZK; Nathan NA; Hornby PJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):14-22. PubMed ID: 9223535
[TBL] [Abstract][Full Text] [Related]
19. Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.
Xi Y; James Chao ZY; Yan W; Abbasi S; Yin X; Mathuria N; Patel M; Fan C; Sun J; Wu G; Wang S; Elayda M; Gao L; Wehrens XH; Lin SF; Cheng J
Heart Rhythm; 2015 Jun; 12(6):1352-61. PubMed ID: 25748673
[TBL] [Abstract][Full Text] [Related]
20. Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation.
Kuncová J; Faitová S; Capouch J; Stengl M; Slavíková J
Physiol Res; 2008; 57(6):827-837. PubMed ID: 18052688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
